NCT00088894View on ClinicalTrials.gov

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

590

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2006

Conditions
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

Given IV

BIOLOGICAL

bevacizumab

Given IV

OTHER

placebo

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacogenomic studies

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00088894 - Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter